 Rebecca Hanratty
Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension | 7 | 2022 | 1295 | 0.700 |
Why?
| | Safety-net Providers | 4 | 2024 | 119 | 0.640 |
Why?
| | Kidney Diseases | 2 | 2011 | 408 | 0.510 |
Why?
| | Patient Discharge | 2 | 2020 | 897 | 0.490 |
Why?
| | Analgesics, Opioid | 3 | 2022 | 1000 | 0.430 |
Why?
| | Electronic Health Records | 3 | 2024 | 1069 | 0.380 |
Why?
| | Pharmacy Service, Hospital | 1 | 2013 | 90 | 0.370 |
Why?
| | Specialization | 1 | 2013 | 144 | 0.370 |
Why?
| | Registries | 5 | 2024 | 2035 | 0.360 |
Why?
| | Telemedicine | 1 | 2020 | 862 | 0.360 |
Why?
| | Medically Underserved Area | 2 | 2010 | 85 | 0.360 |
Why?
| | Antihypertensive Agents | 4 | 2021 | 494 | 0.350 |
Why?
| | Patient-Centered Care | 2 | 2013 | 530 | 0.350 |
Why?
| | Continuity of Patient Care | 1 | 2013 | 284 | 0.340 |
Why?
| | Community Health Workers | 1 | 2010 | 62 | 0.330 |
Why?
| | Racism | 3 | 2021 | 135 | 0.320 |
Why?
| | Blood Pressure | 3 | 2014 | 1786 | 0.300 |
Why?
| | Social Values | 2 | 2021 | 36 | 0.280 |
Why?
| | Medical Records Systems, Computerized | 1 | 2008 | 96 | 0.280 |
Why?
| | Medication Adherence | 4 | 2022 | 467 | 0.280 |
Why?
| | Colorado | 12 | 2024 | 4565 | 0.270 |
Why?
| | Community Health Services | 1 | 2008 | 227 | 0.250 |
Why?
| | Kidney | 2 | 2011 | 1468 | 0.240 |
Why?
| | Opioid-Related Disorders | 2 | 2022 | 515 | 0.220 |
Why?
| | Health Promotion | 1 | 2010 | 741 | 0.220 |
Why?
| | Risk Assessment | 5 | 2021 | 3457 | 0.210 |
Why?
| | Middle Aged | 19 | 2024 | 33479 | 0.200 |
Why?
| | Patient Readmission | 2 | 2021 | 697 | 0.190 |
Why?
| | Pharmacies | 1 | 2022 | 38 | 0.180 |
Why?
| | Referral and Consultation | 2 | 2024 | 786 | 0.180 |
Why?
| | Epidemics | 1 | 2022 | 89 | 0.180 |
Why?
| | Cardiovascular Diseases | 2 | 2010 | 2111 | 0.170 |
Why?
| | Language | 1 | 2024 | 292 | 0.170 |
Why?
| | Hospitalization | 2 | 2023 | 2199 | 0.170 |
Why?
| | Retrospective Studies | 9 | 2022 | 15657 | 0.170 |
Why?
| | Aged | 12 | 2024 | 23961 | 0.170 |
Why?
| | Algorithms | 1 | 2008 | 1704 | 0.170 |
Why?
| | Prescriptions | 1 | 2020 | 67 | 0.170 |
Why?
| | Adult | 16 | 2024 | 37929 | 0.170 |
Why?
| | Physician-Patient Relations | 3 | 2013 | 548 | 0.160 |
Why?
| | Substance-Related Disorders | 2 | 2024 | 1083 | 0.150 |
Why?
| | Buprenorphine | 1 | 2022 | 173 | 0.150 |
Why?
| | Inpatients | 1 | 2023 | 500 | 0.150 |
Why?
| | Humans | 26 | 2024 | 137585 | 0.150 |
Why?
| | Patient Satisfaction | 2 | 2013 | 660 | 0.150 |
Why?
| | Male | 20 | 2024 | 67762 | 0.140 |
Why?
| | Attitude to Health | 1 | 2021 | 439 | 0.140 |
Why?
| | Medical Overuse | 1 | 2018 | 30 | 0.140 |
Why?
| | Female | 20 | 2024 | 73304 | 0.140 |
Why?
| | Hypertrophy, Left Ventricular | 2 | 2008 | 131 | 0.140 |
Why?
| | Drug Overdose | 1 | 2022 | 347 | 0.140 |
Why?
| | Hospitals, Urban | 1 | 2018 | 134 | 0.130 |
Why?
| | Glomerular Filtration Rate | 2 | 2011 | 746 | 0.130 |
Why?
| | Ambulatory Care | 1 | 2020 | 546 | 0.120 |
Why?
| | Models, Statistical | 2 | 2018 | 669 | 0.120 |
Why?
| | Hospitals | 1 | 2020 | 691 | 0.120 |
Why?
| | Incidence | 3 | 2011 | 2804 | 0.120 |
Why?
| | Risk Factors | 6 | 2021 | 10388 | 0.110 |
Why?
| | Primary Health Care | 3 | 2014 | 1738 | 0.110 |
Why?
| | Chi-Square Distribution | 2 | 2012 | 530 | 0.110 |
Why?
| | Electrocardiography | 3 | 2020 | 629 | 0.110 |
Why?
| | Myocardial Infarction | 1 | 2020 | 1046 | 0.100 |
Why?
| | Blood Pressure Determination | 1 | 2014 | 157 | 0.100 |
Why?
| | Healthcare Disparities | 4 | 2024 | 654 | 0.090 |
Why?
| | Telephone | 1 | 2013 | 173 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1639 | 0.090 |
Why?
| | Hyperlipidemias | 1 | 2012 | 120 | 0.090 |
Why?
| | Time Factors | 3 | 2012 | 6828 | 0.090 |
Why?
| | Follow-Up Studies | 3 | 2022 | 5131 | 0.090 |
Why?
| | Professional Role | 1 | 2013 | 167 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1313 | 0.090 |
Why?
| | Proportional Hazards Models | 2 | 2011 | 1266 | 0.090 |
Why?
| | Anticholesteremic Agents | 1 | 2012 | 153 | 0.080 |
Why?
| | Community-Institutional Relations | 1 | 2010 | 98 | 0.080 |
Why?
| | Physicians, Primary Care | 1 | 2013 | 236 | 0.080 |
Why?
| | Young Adult | 5 | 2024 | 13209 | 0.080 |
Why?
| | Linear Models | 1 | 2011 | 849 | 0.080 |
Why?
| | Risk Reduction Behavior | 1 | 2010 | 220 | 0.070 |
Why?
| | Minority Groups | 1 | 2010 | 266 | 0.070 |
Why?
| | United States | 5 | 2024 | 14841 | 0.070 |
Why?
| | Life Style | 1 | 2010 | 490 | 0.070 |
Why?
| | Diabetes Complications | 1 | 2009 | 227 | 0.070 |
Why?
| | Risk | 1 | 2010 | 912 | 0.070 |
Why?
| | Drug Prescriptions | 1 | 2009 | 245 | 0.070 |
Why?
| | Length of Stay | 1 | 2013 | 1215 | 0.070 |
Why?
| | Comorbidity | 2 | 2012 | 1622 | 0.070 |
Why?
| | Socioeconomic Factors | 2 | 2009 | 1289 | 0.070 |
Why?
| | Vascular Diseases | 1 | 2009 | 243 | 0.070 |
Why?
| | Urban Health Services | 2 | 2021 | 63 | 0.060 |
Why?
| | Communication | 1 | 2012 | 879 | 0.060 |
Why?
| | Aged, 80 and over | 2 | 2021 | 7635 | 0.060 |
Why?
| | Logistic Models | 3 | 2021 | 2074 | 0.060 |
Why?
| | Patient Education as Topic | 1 | 2010 | 766 | 0.060 |
Why?
| | Delivery of Health Care | 1 | 2012 | 951 | 0.060 |
Why?
| | Odds Ratio | 2 | 2021 | 1070 | 0.060 |
Why?
| | Survival Analysis | 1 | 2008 | 1325 | 0.060 |
Why?
| | Attitude of Health Personnel | 1 | 2012 | 1171 | 0.060 |
Why?
| | Confidentiality | 1 | 2024 | 73 | 0.050 |
Why?
| | Disease Progression | 1 | 2011 | 2757 | 0.050 |
Why?
| | Diabetes Mellitus | 1 | 2012 | 1040 | 0.050 |
Why?
| | Chronic Disease | 1 | 2009 | 1793 | 0.050 |
Why?
| | Hypoglycemic Agents | 1 | 2012 | 1291 | 0.050 |
Why?
| | Prognosis | 1 | 2011 | 4030 | 0.050 |
Why?
| | Cohort Studies | 2 | 2009 | 5742 | 0.050 |
Why?
| | Mass Screening | 1 | 2010 | 1287 | 0.050 |
Why?
| | Intention to Treat Analysis | 1 | 2021 | 73 | 0.050 |
Why?
| | Single-Blind Method | 1 | 2021 | 282 | 0.040 |
Why?
| | Data Collection | 1 | 2024 | 673 | 0.040 |
Why?
| | Naloxone | 1 | 2022 | 122 | 0.040 |
Why?
| | Health Maintenance Organizations | 2 | 2012 | 108 | 0.040 |
Why?
| | Health Care Surveys | 2 | 2013 | 565 | 0.040 |
Why?
| | Opiate Substitution Treatment | 1 | 2022 | 155 | 0.040 |
Why?
| | Professional-Patient Relations | 1 | 2021 | 145 | 0.040 |
Why?
| | Writing | 1 | 2021 | 95 | 0.040 |
Why?
| | Chest Pain | 1 | 2020 | 91 | 0.040 |
Why?
| | Narcotic Antagonists | 1 | 2022 | 181 | 0.040 |
Why?
| | Adolescent | 3 | 2013 | 21513 | 0.040 |
Why?
| | Mental Disorders | 1 | 2008 | 1077 | 0.040 |
Why?
| | Pharmacists | 1 | 2022 | 265 | 0.040 |
Why?
| | Health Status Disparities | 1 | 2021 | 289 | 0.040 |
Why?
| | Self Report | 1 | 2022 | 827 | 0.030 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2021 | 1329 | 0.030 |
Why?
| | Stereotyped Behavior | 1 | 2012 | 19 | 0.020 |
Why?
| | Cultural Competency | 1 | 2013 | 85 | 0.020 |
Why?
| | Trust | 1 | 2012 | 127 | 0.020 |
Why?
| | Cholesterol, LDL | 1 | 2012 | 365 | 0.020 |
Why?
| | Affect | 1 | 2012 | 292 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2020 | 2069 | 0.020 |
Why?
| | Pilot Projects | 1 | 2014 | 1710 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2008 | 307 | 0.020 |
Why?
| | Nutrition Surveys | 1 | 2008 | 266 | 0.020 |
Why?
| | Prevalence | 1 | 2014 | 2734 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2009 | 1509 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 2031 | 0.010 |
Why?
| | Survival Rate | 1 | 2008 | 1972 | 0.010 |
Why?
| | Biomarkers | 1 | 2012 | 4149 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2012 | 10811 | 0.010 |
Why?
|
|
Hanratty's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|